Senti Biosciences
SNTI
SNTI
15 hedge funds and large institutions have $14.2M invested in Senti Biosciences in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
28% less capital invested
Capital invested by funds: $19.9M → $14.2M (-$5.66M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.82M | |
| 2 | +$655K | |
| 3 | +$372K | |
| 4 |
BlackRock
New York
|
+$57.2K |
| 5 |
Barclays
London,
United Kingdom
|
+$1.71K |
Top Sellers
| 1 | -$1.17M | |
| 2 | -$124K | |
| 3 | -$21.5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$962 |
| 5 |
JP Morgan Chase
New York
|
-$30 |